METTLER TOLEDO INTERNATIONAL INC/ is 23.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($24.18 B vs $1.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EYPT | MTD |
|---|---|---|
| Market cap | $1.03 B | $24.18 B |
| US-listed rank | #2607 | #548 |
| Revenue (latest FY) | $31.37M | $4.03B |
| Net income (latest FY) | -$231.96M | $869.19M |
| Net margin | -739.4% | 21.6% |
| P/E (trailing FY) | - | 27.8 |
| SEC filings | 1,308 | 1,692 |
METTLER TOLEDO INTERNATIONAL INC/ is 23.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($24.18 B vs $1.03 B).
In their latest fiscal years, EyePoint Pharmaceuticals, Inc. reported $31.37M in revenue while METTLER TOLEDO INTERNATIONAL INC/ reported $4.03B.
Full pages: EyePoint Pharmaceuticals, Inc. and METTLER TOLEDO INTERNATIONAL INC/, or browse the full rankings.